Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial

Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov site revision changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T02:12:20.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology, saying federal agencies are using “Super Intelligence” instead of “Artificial Intelligence” under Executive Order 14434.
    Difference
    0.7%
    Check dated 2026-10-25T02:16:01.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T01:58:50.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T02:56:04.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study's history and the previous entry v3.6.6 was removed. This indicates the study record has been updated to a newer revision within the history timeline.
    Difference
    0.1%
    Check dated 2026-09-20T01:26:20.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    A new Revision: v3.6.6 entry was added to the version history, and the previous Revision: v3.6.5 entry was removed. This reflects an update to the page metadata rather than substantive trial data.
    Difference
    0.1%
    Check dated 2026-08-29T20:06:05.000Z thumbnail image

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.